Substituted pyrroline kinase inhibitors

Details Substituted pyrroline kinase inhibitors Substituted pyrroline kinase inhibitors

2004-03-03

2009-02-10

Morris, Patricia L (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07488826

ABSTRACT:
The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.

REFERENCES:
patent: 5057614 (1991-10-01), Davis et al.
patent: 6849643 (2005-02-01), Zhang et al.
patent: 6987110 (2006-01-01), Zhang et al.
patent: 7001906 (2006-02-01), Prudhomme et al.
patent: 7125878 (2006-10-01), Zhang et al.
patent: 2004/0054180 (2004-03-01), Zhang et al.
patent: 2004/0259928 (2004-12-01), Zhang et al.
patent: 2005/0004201 (2005-01-01), Zhang et al.
patent: 2005/0004202 (2005-01-01), Zhang et al.
patent: 2006/0205762 (2006-09-01), Zhang et al.
patent: 2006/0205763 (2006-09-01), Zhang et al.
patent: WO 95/07910 (1995-03-01), None
patent: WO 00/21927 (2000-04-01), None
patent: WO 00/38675 (2000-07-01), None
patent: WO 03/002563 (2003-01-01), None
patent: WO 03/095452 (2003-11-01), None
PCT International Search Report, dated Jul. 16, 2004, for PCT Int'l. Appln. No. PCT/US2004/006424.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, De, Database Accession No. 5386104(BRN) and J. Med. Chem., vol. 35, No. 6, 1992, pp. 994-1001.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, De, Database Accession No. 5366323 (BRN) and Biochem. Pharmacol., vol. 50, No. 2, 1995, pp. 197-204.
Davis P.D. et al., “Inhibitors of Protein Kinase C 1. 2,3-Bisarylmaleimides”, Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 35, No. 1, 1992, pp. 177-184.
Hers, I. et al., “The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31-8220) are potent inhibitors of glycogen synthase kinaase-3 activity”, FEBS Letters, Elsevier Science Publishers, Amsterdam, NL., vol. 460, No. 3, Nov. 5, 1999, pp. 433-436.
Smith, D.G. et al., “3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase Kinase=3 (GSK-3)”, Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 11, No. 5, Mar. 12, 2001, pp. 635-639.

Affiliated with

Also associated with

Rating

Substituted pyrroline kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyrroline kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrroline kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4103699